BR6915159D0 - Processo para a preparacao de n-alquil-1 4-di-hidropiridinas - Google Patents

Processo para a preparacao de n-alquil-1 4-di-hidropiridinas

Info

Publication number
BR6915159D0
BR6915159D0 BR215159/69A BR21515969A BR6915159D0 BR 6915159 D0 BR6915159 D0 BR 6915159D0 BR 215159/69 A BR215159/69 A BR 215159/69A BR 21515969 A BR21515969 A BR 21515969A BR 6915159 D0 BR6915159 D0 BR 6915159D0
Authority
BR
Brazil
Prior art keywords
hydropyridids
alkyl
preparation
Prior art date
Application number
BR215159/69A
Other languages
English (en)
Inventor
F Bossert
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of BR6915159D0 publication Critical patent/BR6915159D0/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
BR215159/69A 1969-05-10 1969-12-15 Processo para a preparacao de n-alquil-1 4-di-hidropiridinas BR6915159D0 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1923990A DE1923990C3 (de) 1969-05-10 1969-05-10 Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern

Publications (1)

Publication Number Publication Date
BR6915159D0 true BR6915159D0 (pt) 1973-04-19

Family

ID=5733869

Family Applications (1)

Application Number Title Priority Date Filing Date
BR215159/69A BR6915159D0 (pt) 1969-05-10 1969-12-15 Processo para a preparacao de n-alquil-1 4-di-hidropiridinas

Country Status (15)

Country Link
US (1) US3773773A (pt)
JP (1) JPS4935277B1 (pt)
AT (1) AT299200B (pt)
BE (1) BE750139A (pt)
BR (1) BR6915159D0 (pt)
DE (1) DE1923990C3 (pt)
DK (1) DK136246B (pt)
FI (1) FI52078C (pt)
FR (1) FR2051515B1 (pt)
GB (1) GB1305793A (pt)
IL (1) IL34304A (pt)
NL (1) NL7006628A (pt)
NO (1) NO133274C (pt)
SE (1) SE376915B (pt)
YU (1) YU33268B (pt)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963188A1 (de) * 1969-12-17 1971-06-24 Bayer Ag Neue Cyanphenyl-1,4-dihydropyridinderivate
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2117572C3 (de) * 1971-04-10 1980-03-20 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin ^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US4021434A (en) * 1972-01-22 1977-05-03 Yamanouchi Pharmaceutical Co., Ltd. Sodium β-[2,6-dimethyl-3,5-bis(ethoxycarbonyl)-4-(3-nitrophenyl)-1,4-dihydropyridine-1-yl]ethyl sulfate
GB1430961A (en) * 1972-01-22 1976-04-07 Yamanouchi Pharma Co Ltd 1-substituted-1,4-dihyddrypyridine derivatives
US3933834A (en) * 1972-03-06 1976-01-20 Bayer Aktiengesellschaft Unsymmetrical esters of N-substituted 1,4-dihydropyridine 3,5-dicarboxylic acid
US3887558A (en) * 1972-03-06 1975-06-03 Bayer Ag Process for producing 2,6-diamino -1,4- dihydro-3,5-pyridine-dicarboxylates and derivatives thereof
US3939171A (en) * 1972-03-06 1976-02-17 Bayer Aktiengesellschaft 2-Amino-1,4-dihydropyridine derivatives
US3935223A (en) * 1972-03-06 1976-01-27 Bayer Aktiengesellschaft 2-Amino-1,4-dihydropyridine derivatives
US3917620A (en) * 1972-03-06 1975-11-04 Bayer Ag 2-Amino-4,5-dihydropyridine derivatives
US3857849A (en) * 1973-02-28 1974-12-31 Bayer Ag 2-amino-1,4-dihydropyridine derivatives
US3992545A (en) * 1972-03-06 1976-11-16 Bayer Aktiengesellschaft 2-Amino-4,5-dihydropyridine derivatives in pharmaceutical compositions
US3957998A (en) * 1972-03-06 1976-05-18 Bayer Aktiengesellschaft Use of 2,6-diamino-4-substituted-1,4-dihydropyridine-3,5-dicarboxylic acid esters for effecting coronary vessel dilation and treating hypertension
DE2210674C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2-Amino-6-methyl-1,4-dihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
US3988458A (en) * 1972-03-06 1976-10-26 Bayer Aktiengesellschaft Bicyclic derivatives of 1,4-dihydropyridine 3,5-carboxylic acid esters
US3985886A (en) * 1972-03-06 1976-10-12 Bayer Aktiengesellschaft 2-Amino-4,5-dihydropyridine derivatives and process for their preparation
DD106832A5 (pt) * 1972-03-06 1974-07-05
DE2218644C3 (de) * 1972-04-18 1982-08-19 Bayer Ag, 5090 Leverkusen Basische Ester von 1,4-Dihydropyridinen, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2228363A1 (de) * 1972-06-10 1974-01-03 Bayer Ag 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US3968117A (en) * 1972-06-10 1976-07-06 Bayer Aktiengesellschaft 1,4-Dihydropyridines
DE2239815C2 (de) * 1972-08-12 1983-02-10 Bayer Ag, 5090 Leverkusen 2-Alkylamino-dihydropyridine, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
US4136187A (en) * 1972-08-12 1979-01-23 Bayer Aktiengesellschaft Antihypertensive 2-amino-4,5-dihydropyridine derivatives
DE2242786A1 (de) * 1972-08-31 1974-03-14 Bayer Ag Verfahren zur herstellung von neuen 2-amino-1,4-dihydropyridinen mit einer carbonylfunktion sowie ihre verwendung als arzneimittel
DE2242787C2 (de) * 1972-08-31 1982-01-21 Bayer Ag, 5090 Leverkusen 4-Phenyl-6-amino-3,4-dihydropyridon-(2)-3,5-dicarbonsäure-diäthylesterderivate, ein Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
GB1409865A (en) * 1973-02-13 1975-10-15 Science Union & Cie Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them
FR2218107A1 (en) * 1973-02-20 1974-09-13 Yamanouchi Pharma Co Ltd Amino alkyl 2,6-dialkyl-4-aryl-1,4 dihydropyridine-3, carboxylates - useful as cerebral vasodilators and musculotropic spasmolytic agents
US4002762A (en) * 1973-03-03 1977-01-11 Bayer Aktiengesellschaft 2-Amino-3,4-dihydropyridines used to effect coronary vessel dilation and treat hypertension
GB1425729A (en) * 1973-06-12 1976-02-18 Smith Kline French Lab 1,4-dihydropyridine compounds
DE2335466A1 (de) * 1973-07-12 1975-01-30 Bayer Ag Alkoxyalkyl-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4020178A (en) * 1973-07-12 1977-04-26 Bayer Aktiengesellschaft 1,4-Dihydropyridine esters used as coronary dilators and anti-hypertensives
FR2320750A1 (fr) * 1975-08-12 1977-03-11 Hexachimie Dihydro-1,4 pyridines et leur application therapeutique
US4466972A (en) * 1977-06-20 1984-08-21 Sandoz Ltd. Benzoxadiazoles and benzothiadiazoles, their preparation and pharmaceutical compositions containing them
DE2738153A1 (de) * 1977-08-24 1979-03-08 Bayer Ag 2-pyridyl-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
FR2405937A1 (fr) * 1977-10-14 1979-05-11 Labaz Nouveaux derives de dihydropyridine, leur procede de preparation et leur application
SU798099A1 (ru) * 1978-03-06 1981-01-23 Ордена Трудового Красного Знамениинститут Органического Синтезаан Латвийской Ccp 1-Бензил-2,6-диметил-4-о-или-M-НиТРОфЕНил-3,5-диэТОКСиКАРбОНил- 1,4-дигидРОпиРидиНы, пРО Вл ющиЕКОРОНАРОдилАТиРующую АКТиВНОСТь
DE3022030A1 (de) * 1980-06-12 1981-12-17 Bayer Ag, 5090 Leverkusen 4-thiazol- bzw. 4-imidazol-substituierte, 1,4-dihydropyridine, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
US4365063A (en) * 1981-08-31 1982-12-21 American Home Products Corporation Antihypertensive agents
US4321384A (en) * 1981-02-27 1982-03-23 American Home Products Corporation Antihypertensive agents
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
JPS58159490A (ja) * 1982-02-23 1983-09-21 Nikken Kagaku Kk １，４−ジヒドロピリジン化合物
US4500532A (en) * 1983-03-03 1985-02-19 Usv Pharmaceutical Corporation 1-(Substituted aminoalkyl)-1,4-dihydropyridines
US4771057A (en) * 1986-02-03 1988-09-13 University Of Alberta Reduced pyridyl derivatives with cardiovascular regulating properties
EP0388482B1 (de) * 1989-03-20 1994-07-06 Siemens Aktiengesellschaft Lichtempfindliches Gemisch
US5258521A (en) * 1989-07-26 1993-11-02 Tosoh Corporation Process of producing optically active propionic acid ester derivatives
DE4011695A1 (de) * 1990-04-11 1991-10-17 Bayer Ag Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsaeureestern als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung
DE4125271A1 (de) * 1991-07-31 1993-02-11 Bayer Ag Neue n-alkylierte 1,4-dihydropyridindicarbonsaeureester
DE4133257A1 (de) * 1991-10-08 1993-04-15 Bayer Ag N-methyl-nimodipin, verfahren zu seiner herstellung und seine verwendung als zerebraltherapeutikum
DE4223867A1 (de) * 1992-07-20 1994-01-27 Bayer Ag Spezieller 1,4-Dihydropyridin-3,5-dicarbonsäureester, Verfahren zu seiner Herstellung und seine pharmazeutische Verwendung
DE4430094A1 (de) 1994-08-25 1996-02-29 Bayer Ag Verwendung von 3,5-Dicarbonsäureester-1,4-Dihydropyridinen als Arzneimittel
JPH1039510A (ja) * 1996-07-29 1998-02-13 Nitto Denko Corp ネガ型フォトレジスト組成物及びその利用
AU747705C (en) * 1997-12-13 2004-09-23 Bristol-Myers Squibb Company Use of pyrazolo (3,4-b) pyridine as cyclin dependent kinase inhibitors
US6653481B2 (en) * 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine
CN110606822A (zh) * 2011-11-24 2019-12-24 里克特吉迪翁公司 具有hsp调节活性的1,4-二氢吡啶衍生物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3325505A (en) * 1965-02-24 1967-06-13 Smith Kline French Lab 4-cycloalkyl(or cycloalkenyl)-dihydropyridines
US3441648A (en) * 1967-02-07 1969-04-29 Smithkline Corp Compositions and methods for lowering blood pressure with 1,4-dihydropyridines

Also Published As

Publication number Publication date
FR2051515A1 (pt) 1971-04-09
GB1305793A (pt) 1973-02-07
AT299200B (de) 1972-06-12
NL7006628A (pt) 1970-11-12
FR2051515B1 (pt) 1974-07-12
DE1923990B2 (de) 1978-03-30
YU102670A (en) 1976-03-31
IL34304A (en) 1973-06-29
NO133274C (pt) 1976-04-07
DE1923990C3 (de) 1978-11-23
BE750139A (pt) 1970-11-09
US3773773A (en) 1973-11-20
FI52078C (fi) 1977-06-10
FI52078B (pt) 1977-02-28
DK136246B (da) 1977-09-12
DE1923990A1 (de) 1970-11-19
DK136246C (pt) 1978-02-13
NO133274B (pt) 1975-12-29
SE376915B (pt) 1975-06-16
IL34304A0 (en) 1970-06-17
YU33268B (en) 1976-08-31
JPS4935277B1 (pt) 1974-09-20

Similar Documents

Publication Publication Date Title
BR6915159D0 (pt) Processo para a preparacao de n-alquil-1 4-di-hidropiridinas
BR7019570D0 (pt) Processo para a preparacao de mercapto-alquil-alcoxi-silanas
BR6915466D0 (pt) Processo para a preparacao de peperazinil-alquilaminourac
BR7019965D0 (pt) Processo para a preparacao de imidazois
BR6915189D0 (pt) Processo para a preparacao de compostos da hexafuranose
BR6915286D0 (pt) Processo para a preparacao de tiofeno-sulfonil-ureias
BR6915371D0 (pt) Processo para a preparacao de derivados benzomorfonicos
BR6915221D0 (pt) Processo para a fabricacao de derivados de morfilina
BR7011339D0 (pt) Processo para a preparacao de derivados de aminopiperidin
BR6915195D0 (pt) Processo para a preparacao de anilidas de acidos 3-acilgama-resorcilicos
BR7016656D0 (pt) Processo para a preparacao de gama-cianobutiraldiminas
BR6915097D0 (pt) Processo para a preparacao de derivados de tritilimidozol
BR6906644D0 (pt) Processo para a preparacao de cromanois
BR6915006D0 (pt) Processo para a preparacao do di-n-oxido-aldeido de quinoxatina
BR7107425D0 (pt) Processo para a preparacao de metacroleina
BR7101126D0 (pt) Processo para a preparacao de xilose
BR6915196D0 (pt) Processo para a preparacao de 21-ennantato de galfa-fluor-16-fluormetileno-prednisolona
BR7016708D0 (pt) Processo para a preparacao de derivados de fenilo
BR6915158D0 (pt) Processo para a preparacao de n-tritilimidazois e n-tritiltriazois
BR6915120D0 (pt) Processo para a preparacao de hidrazinopirimidinas
BR6915156D0 (pt) Processo para a preparacao de n-tritilimidazois e-triazoi
BR6915269D0 (pt) Processo para a preparacao de 2-oxo-1-2-dihidro-3-h-1-1-4-benzodiazepinas
BR6915479D0 (pt) Processo para a preparacao de 17-eteres 2-androstenicos basicos
BR7105298D0 (pt) Um processo para preparacao de bipiridis
BR7017529D0 (pt) Processo aperfeicoado para a preparacao de 3 beta-hidroxi-delta 5(10)-esteroides